Download PDF
Thorac Cardiovasc Surg 2023; 71(05): 398-406
DOI: 10.1055/s-0041-1727138
Original Cardiovascular

Left Ventricular Diastolic Dysfunction and Pulmonary Hypertension: Outcomes in SAVR

Tom X. Liu 
1   School of Medicine, Virginia Tech Carilion School of Medicine, Roanoke, Virginia, United States
2   Department of Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, United States
,
Mira T. Tanenbaum
1   School of Medicine, Virginia Tech Carilion School of Medicine, Roanoke, Virginia, United States
,
Claire H. Seo
1   School of Medicine, Virginia Tech Carilion School of Medicine, Roanoke, Virginia, United States
,
Dan Park
1   School of Medicine, Virginia Tech Carilion School of Medicine, Roanoke, Virginia, United States
,
John C. Lystash
2   Department of Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, United States
,
Mark Joseph
2   Department of Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, United States
,
William S. Arnold
2   Department of Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, United States
› Author Affiliations Funding None.
› Further Information
    Permissions and Reprints All articles of this category

Abstract

Background Severe pulmonary hypertension (PH) and left ventricular diastolic dysfunction (LVDD) are independently associated with poor outcomes in cardiac surgery. We evaluated the relationship of several measures of LVDD, PH, and hemodynamic subtypes of PH including precapillary pulmonary hypertension(pcPH) and isolated post-capillary pulmonary hypertension(ipcPH) and combined pre and post capillary pulmonary hypertension(cpcPH) capillary PH to postoperative outcomes in a cohort of patients who underwent elective isolated-AVR.

Methods We evaluated (n = 206) patients in our local STS database who underwent elective isolated-AVR between 2014 and 2018, with transthoracic echocardiogram (n = 177) or right heart catheterization (n = 183) within 1 year of operation (or both, n = 161). The primary outcome was a composite end point of death, prolonged ventilation, ICU readmission, and hospital stay >14 days.

Results Severe PH was associated with worse outcomes (moderate: OR, 1.1, p = 0.09; severe: OR, 1.28, p = 0.01), but degree of LVDD was not associated with worse outcomes. Across hemodynamic subtypes of PH, odds of composite outcome were similar (p = 0.89), however, patients with cpcPH had more postoperative complications (67 vs. 36%, p = 0.06) and patients with ipcPH had greater all-cause mortality at 1 (8 vs. 1%, p = 0.03) and 3 years (27 vs. 4%, p = 0.008).

Conclusion Severe PH conferred modestly greater risk of adverse events, and both LVDD grade and the combination of severe PH and LVDD were not associated with worse outcomes. However, hemodynamic stratification of PH revealed higher postoperative complications and worse long-term outcomes for those with cpcPH and ipcPH. Preoperative stratification of PH by hemodynamic subtype in valve replacement surgery may improve our risk stratification in this heterogenous condition. Further evaluation of the significance of LVDD and PH in other cardiac operations is warranted.

Keywords

aortic valve - cardiac - cardiology - heart valve surgery

Data Availability Statement

Data available from the corresponding author on reasonable request.


Authors' Contribution

T.L. reviewed the literature, performed analysis, wrote, and edited the manuscript. M.T. was instrumental to the study design and contributed to data collection, critical writing of and revision the manuscript. C.S., D.P., J.L., and W.S.A. contributed to data collection and analysis. J.L. and M.J. contributed to study design and advised the study in addition to revising the manuscript. W.S.A. supervised the work and revised the manuscript critically for important intellectual content. All authors reviewed the manuscript and approved the final version.


Supplementary Material



Publication History

Received: 23 August 2020

Accepted: 09 February 2021

Article published online:
16 April 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Morozowich ST, Murray AW, Ramakrishna H. Pulmonary hypertension in patients for transcatheter and surgical aortic valve replacement: a focus on outcomes and perioperative management. J Cardiothorac Vasc Anesth 2018; 32 (04) 2005-2018
    CrossrefPubMedGoogle Scholar
  • 2 Georgiopoulou VV, Kalogeropoulos AP, Borlaug BA, Gheorghiade M, Butler J. Left ventricular dysfunction with pulmonary hypertension: part 1: epidemiology, pathophysiology, and definitions. Circ Heart Fail 2013; 6 (02) 344-354
    CrossrefPubMedGoogle Scholar
  • 3 Schewel J, Schmidt T, Kuck KH, Frerker C, Schewel D. Impact of pulmonary hypertension hemodynamic status on long-term outcome after transcatheter aortic valve replacement. JACC Cardiovasc Interv 2019; 12 (21) 2155-2168
    CrossrefPubMedGoogle Scholar
  • 4 Naeije R, Chin K. Differentiating precapillary from postcapillary pulmonary hypertension. Circulation 2019; 140 (09) 712-714
    CrossrefPubMedGoogle Scholar
  • 5 Carabello BA, Paulus WJ. Aortic stenosis. Lancet 2009; 373 (9667): 956-966
    CrossrefPubMedGoogle Scholar
  • 6 Cho DH, Park SM, Kim MN, Kim SA, Lim H, Shim WJ. Presence of preoperative diastolic dysfunction predicts postoperative pulmonary edema and cardiovascular complications in patients undergoing noncardiac surgery. Echocardiography 2014; 31 (01) 42-49
    CrossrefPubMedGoogle Scholar
  • 7 Afilalo J, Flynn AW, Shimony A. et al. Incremental value of the preoperative echocardiogram to predict mortality and major morbidity in coronary artery bypass surgery. Circulation 2013; 127 (03) 356-364
    CrossrefPubMedGoogle Scholar
  • 8 Malouf JF, Enriquez-Sarano M, Pellikka PA. et al. Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications. J Am Coll Cardiol 2002; 40 (04) 789-795
    CrossrefPubMedGoogle Scholar
  • 9 D'Agostino RS, Jacobs JP, Badhwar V. et al. The society of thoracic surgeons adult cardiac surgery database: 2019 update; outcomes and quality. Ann Thorac Surg 2019; 107 (01) 24-32
    CrossrefPubMedGoogle Scholar
  • 10 Fogel SL, Reed CR, Baker CC. An evaluation of risk stratification in general surgery patients. Am Surg 2017; 83 (11) e450-e451
    CrossrefPubMedGoogle Scholar
  • 11 Kampaktsis PN, Kokkinidis DG, Wong SC, Vavuranakis M, Skubas NJ, Devereux RB. The role and clinical implications of diastolic dysfunction in aortic stenosis. Heart 2017; 103 (19) 1481-1487
    CrossrefPubMedGoogle Scholar
  • 12 Kennedy JLW, LaPar DJ, Kern JA. et al. Does the Society of Thoracic Surgeons risk score accurately predict operative mortality for patients with pulmonary hypertension?. J Thorac Cardiovasc Surg 2013; 146 (03) 631-637
    CrossrefPubMedGoogle Scholar
  • 13 Ben-Dor I, Goldstein SA, Pichard AD. et al. Clinical profile, prognostic implication, and response to treatment of pulmonary hypertension in patients with severe aortic stenosis. Am J Cardiol 2011; 107 (07) 1046-1051
    CrossrefPubMedGoogle Scholar
  • 14 Metkus TS, Suarez-Pierre A, Crawford TC. et al. Diastolic dysfunction is common and predicts outcome after cardiac surgery. J Cardiothorac Surg 2018; 13 (01) 67-67
    CrossrefPubMedGoogle Scholar
  • 15 Melby SJ, Moon MR, Lindman BR, Bailey MS, Hill LL, Damiano Jr RJ. Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J Thorac Cardiovasc Surg 2011; 141 (06) 1424-1430
    CrossrefPubMedGoogle Scholar
  • 16 Vaskelyte J, Stoskute N, Kinduris S, Ereminiene E. Coronary artery bypass grafting in patients with severe left ventricular dysfunction: predictive significance of left ventricular diastolic filling pattern. Eur J Echocardiogr 2001; 2 (01) 62-67
    CrossrefPubMedGoogle Scholar
  • 17 Gössl M, Kane GC, Mauermann W, Holmes DR. Pulmonary hypertension in patients undergoing transcatheter aortic valve replacement: discussion of the current evidence. Circ Cardiovasc Interv 2015; 8 (06) e002253
    CrossrefPubMedGoogle Scholar
  • 18 Apostolakis EE, Baikoussis NG, Parissis H, Siminelakis SN, Papadopoulos GS. Left ventricular diastolic dysfunction of the cardiac surgery patient; a point of view for the cardiac surgeon and cardio-anesthesiologist. J Cardiothorac Surg 2009; 4: 67-67
    CrossrefPubMedGoogle Scholar
  • 19 O'Sullivan CJ, Wenaweser P, Ceylan O. et al. Effect of pulmonary hypertension hemodynamic presentation on clinical outcomes in patients with severe symptomatic aortic valve stenosis undergoing transcatheter aortic valve implantation: insights from the new proposed pulmonary hypertension classification. Circ Cardiovasc Interv 2015; 8 (07) e002358
    CrossrefPubMedGoogle Scholar
  • 20 Shahian DM, O'Brien SM, Filardo G. et al; Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1—coronary artery bypass grafting surgery. Ann Thorac Surg 2009; 88 (Suppl. 01) S2-S22
    CrossrefPubMedGoogle Scholar
  • 21 Nashef SA, Roques F, Sharples LD. et al. EuroSCORE II. Eur J Cardiothorac Surg 2012; 41 (04) 734-744 , discussion 744–745
    CrossrefPubMedGoogle Scholar
  • 22 Galiè N, Humbert M, Vachiery J-L. et al; ESC Scientific Document Group. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society Of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016; 37 (01) 67-119
    CrossrefPubMedGoogle Scholar
  • 23 Nilsson J, Algotsson L, Höglund P, Lührs C, Brandt J. Comparison of 19 pre-operative risk stratification models in open-heart surgery. Eur Heart J 2006; 27 (07) 867-874
    CrossrefPubMedGoogle Scholar
  • 24 Nagueh SF, Smiseth OA, Appleton CP. et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2016; 29 (04) 277-314
    CrossrefPubMedGoogle Scholar
  • 25 Swaminathan M, Nicoara A, Phillips-Bute BG. et al; Cardiothoracic Anesthesia Research Endeavors (CARE) Group. Utility of a simple algorithm to grade diastolic dysfunction and predict outcome after coronary artery bypass graft surgery. Ann Thorac Surg 2011; 91 (06) 1844-1850
    CrossrefPubMedGoogle Scholar
  • 26 Gille J, Seyfarth H-J, Gerlach S, Malcharek M, Czeslick E, Sablotzki A. Perioperative anesthesiological management of patients with pulmonary hypertension. Anesthesiol Res Pract 2012; 2012: 356982-356982
    PubMedGoogle Scholar
  • 27 Fischer LG, Van Aken H, Bürkle H. Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists. Anesth Analg 2003; 96 (06) 1603-1616
    CrossrefPubMedGoogle Scholar
  • 28 Sparrow CT, LaRue SJ, Schilling JD. Intersection of pulmonary hypertension and right ventricular dysfunction in patients on left ventricular assist device support. Circ Heart Fail 2018; 11 (01) e004255
    CrossrefPubMedGoogle Scholar
  • 29 Bishu K, Suri RM, Nkomo VT. et al. Prognostic impact of pulmonary artery systolic pressure in patients undergoing transcatheter aortic valve replacement for aortic stenosis. Am J Cardiol 2014; 114 (10) 1562-1567
    CrossrefPubMedGoogle Scholar